Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivors
Identifieur interne : 006801 ( Main/Exploration ); précédent : 006800; suivant : 006802Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivors
Auteurs : Kathryn H. Schmitz [États-Unis] ; Andrea B. Troxel [États-Unis] ; Andrea Cheville [États-Unis] ; Lorita L. Grant [États-Unis] ; Cathy J. Bryan [États-Unis] ; Cynthia R. Gross [États-Unis] ; Leslie A. Lytle [États-Unis] ; Rehana L. Ahmed [États-Unis]Source :
- Contemporary clinical trials [ 1551-7144 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Complications postopératoires (psychologie), Complications postopératoires (rééducation et réadaptation), Entraînement en résistance (effets indésirables), Femelle, Humains, Lymphoedème (psychologie), Lymphoedème (rééducation et réadaptation), Qualité de vie (psychologie), Sujet âgé, Survivants, Tumeurs du sein (), Tumeurs du sein (psychologie), Tumeurs du sein (radiothérapie), Tumeurs du sein (rééducation et réadaptation), Études de suivi.
- MESH :
- effets indésirables : Entraînement en résistance.
- psychologie : Complications postopératoires, Lymphoedème, Qualité de vie, Tumeurs du sein.
- radiothérapie : Tumeurs du sein.
- rééducation et réadaptation : Complications postopératoires, Lymphoedème, Tumeurs du sein.
- Pascal (Inist)
- Adulte, Adulte d'âge moyen, Exercice physique, Femelle, Humains, Lymphoedème, Essai clinique, Sujet âgé, Survivants, Toxicité, Sécurité, Résistance mécanique, Cancer du sein, Homme, Survivant, Méthodologie, Evaluation performance, Analyse statistique, Protocole expérimental, Tumeurs du sein, Études de suivi.
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adult, Aged, Breast Neoplasms (psychology), Breast Neoplasms (radiotherapy), Breast Neoplasms (rehabilitation), Breast Neoplasms (surgery), Breast cancer, Clinical trial, Experimental protocol, Female, Follow-Up Studies, Human, Humans, Lymphedema, Lymphedema (psychology), Lymphedema (rehabilitation), Methodology, Middle Aged, Performance evaluation, Physical exercise, Postoperative Complications (psychology), Postoperative Complications (rehabilitation), Quality of Life (psychology), Resistance Training (adverse effects), Safety, Statistical analysis, Strength, Survivor, Survivors, Toxicity.
- MESH :
- adverse effects : Resistance Training.
- psychology : Breast Neoplasms, Lymphedema, Postoperative Complications, Quality of Life.
- radiotherapy : Breast Neoplasms.
- rehabilitation : Breast Neoplasms, Lymphedema, Postoperative Complications.
- surgery : Breast Neoplasms.
- Adult, Aged, Female, Follow-Up Studies, Humans, Middle Aged, Survivors.
Abstract
Lymphedema is a chronic and progressive long-term adverse effect of breast cancer treatment commonly defined by swelling of the affected arm. Current clinical guidelines indicate that women with and at risk for lymphedema should protect the affected arm from overuse. In clinical practice, this often translates into risk aversive guidance to avoid using the arm. This could lead to a disuse pattern that may increase the likelihood of injury from common activities of daily living. Further, such guidance poses an additional barrier to staying physically active, potentially translating to weight gain, which has been shown to be associated with worse clinical course for women with lymphedema. We hypothesize that a program of slowly progressive strength training with no upper limit on the amount of weight that may be lifted would gradually increase the physiologic capacity of the arm so that common activities represent a decreasing percentage of maximal capacity. Theoretically, this increased capacity should decrease the risk that daily activities put stress on the lymphatic system of the affected side. The Physical Activity and Lymphedema (PAL) Trial is a recently completed randomized controlled exercise intervention trial that recruited 295 breast cancer survivors (141 with lymphedema at study entry, 154 at risk for lymphedema at study entry). The purpose of this report is to provide detail regarding the study design, statistical design, and protocol of the PAL trial.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000329
- to stream PascalFrancis, to step Curation: 000629
- to stream PascalFrancis, to step Checkpoint: 000315
- to stream Main, to step Merge: 006885
- to stream Pmc, to step Corpus: 002820
- to stream Pmc, to step Curation: 002819
- to stream Pmc, to step Checkpoint: 003630
- to stream PubMed, to step Corpus: 002F95
- to stream PubMed, to step Curation: 002F95
- to stream PubMed, to step Checkpoint: 002F95
- to stream Ncbi, to step Merge: 003182
- to stream Ncbi, to step Curation: 003182
- to stream Ncbi, to step Checkpoint: 003182
- to stream Main, to step Merge: 006178
- to stream Main, to step Curation: 006801
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivors</title>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Troxel, Andrea B" sort="Troxel, Andrea B" uniqKey="Troxel A" first="Andrea B." last="Troxel">Andrea B. Troxel</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cheville, Andrea" sort="Cheville, Andrea" uniqKey="Cheville A" first="Andrea" last="Cheville">Andrea Cheville</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Mayo Clinic</s1>
<s2>Rochester, MN</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grant, Lorita L" sort="Grant, Lorita L" uniqKey="Grant L" first="Lorita L." last="Grant">Lorita L. Grant</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bryan, Cathy J" sort="Bryan, Cathy J" uniqKey="Bryan C" first="Cathy J." last="Bryan">Cathy J. Bryan</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Cynthia R" sort="Gross, Cynthia R" uniqKey="Gross C" first="Cynthia R." last="Gross">Cynthia R. Gross</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lytle, Leslie A" sort="Lytle, Leslie A" uniqKey="Lytle L" first="Leslie A." last="Lytle">Leslie A. Lytle</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0268266</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0268266 INIST</idno>
<idno type="RBID">Pascal:09-0268266</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000329</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000629</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000315</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000315</idno>
<idno type="wicri:doubleKey">1551-7144:2009:Schmitz K:physical:activity:and</idno>
<idno type="wicri:Area/Main/Merge">006885</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730488</idno>
<idno type="RBID">PMC:2730488</idno>
<idno type="wicri:Area/Pmc/Corpus">002820</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002820</idno>
<idno type="wicri:Area/Pmc/Curation">002819</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002819</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003630</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003630</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002F95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F95</idno>
<idno type="wicri:Area/PubMed/Curation">002F95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F95</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F95</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F95</idno>
<idno type="wicri:Area/Ncbi/Merge">003182</idno>
<idno type="wicri:Area/Ncbi/Curation">003182</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003182</idno>
<idno type="wicri:doubleKey">1551-7144:2009:Schmitz K:physical:activity:and</idno>
<idno type="wicri:Area/Main/Merge">006178</idno>
<idno type="wicri:Area/Main/Curation">006801</idno>
<idno type="wicri:Area/Main/Exploration">006801</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivors</title>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Troxel, Andrea B" sort="Troxel, Andrea B" uniqKey="Troxel A" first="Andrea B." last="Troxel">Andrea B. Troxel</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cheville, Andrea" sort="Cheville, Andrea" uniqKey="Cheville A" first="Andrea" last="Cheville">Andrea Cheville</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Mayo Clinic</s1>
<s2>Rochester, MN</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grant, Lorita L" sort="Grant, Lorita L" uniqKey="Grant L" first="Lorita L." last="Grant">Lorita L. Grant</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bryan, Cathy J" sort="Bryan, Cathy J" uniqKey="Bryan C" first="Cathy J." last="Bryan">Cathy J. Bryan</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>University of Pennsylvania School of Medicine</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Cynthia R" sort="Gross, Cynthia R" uniqKey="Gross C" first="Cynthia R." last="Gross">Cynthia R. Gross</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lytle, Leslie A" sort="Lytle, Leslie A" uniqKey="Lytle L" first="Leslie A." last="Lytle">Leslie A. Lytle</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>University of Minnesota</s1>
<s2>Minneapolis, MN</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Contemporary clinical trials</title>
<title level="j" type="abbreviated">contemp. clin. trials</title>
<idno type="ISSN">1551-7144</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Contemporary clinical trials</title>
<title level="j" type="abbreviated">contemp. clin. trials</title>
<idno type="ISSN">1551-7144</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Breast Neoplasms (psychology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (rehabilitation)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Breast cancer</term>
<term>Clinical trial</term>
<term>Experimental protocol</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Lymphedema</term>
<term>Lymphedema (psychology)</term>
<term>Lymphedema (rehabilitation)</term>
<term>Methodology</term>
<term>Middle Aged</term>
<term>Performance evaluation</term>
<term>Physical exercise</term>
<term>Postoperative Complications (psychology)</term>
<term>Postoperative Complications (rehabilitation)</term>
<term>Quality of Life (psychology)</term>
<term>Resistance Training (adverse effects)</term>
<term>Safety</term>
<term>Statistical analysis</term>
<term>Strength</term>
<term>Survivor</term>
<term>Survivors</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Complications postopératoires (psychologie)</term>
<term>Complications postopératoires (rééducation et réadaptation)</term>
<term>Entraînement en résistance (effets indésirables)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (psychologie)</term>
<term>Lymphoedème (rééducation et réadaptation)</term>
<term>Qualité de vie (psychologie)</term>
<term>Sujet âgé</term>
<term>Survivants</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (psychologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (rééducation et réadaptation)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Resistance Training</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Entraînement en résistance</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
<term>Qualité de vie</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
<term>Postoperative Complications</term>
<term>Quality of Life</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Survivors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Exercice physique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Essai clinique</term>
<term>Sujet âgé</term>
<term>Survivants</term>
<term>Toxicité</term>
<term>Sécurité</term>
<term>Résistance mécanique</term>
<term>Cancer du sein</term>
<term>Homme</term>
<term>Survivant</term>
<term>Méthodologie</term>
<term>Evaluation performance</term>
<term>Analyse statistique</term>
<term>Protocole expérimental</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema is a chronic and progressive long-term adverse effect of breast cancer treatment commonly defined by swelling of the affected arm. Current clinical guidelines indicate that women with and at risk for lymphedema should protect the affected arm from overuse. In clinical practice, this often translates into risk aversive guidance to avoid using the arm. This could lead to a disuse pattern that may increase the likelihood of injury from common activities of daily living. Further, such guidance poses an additional barrier to staying physically active, potentially translating to weight gain, which has been shown to be associated with worse clinical course for women with lymphedema. We hypothesize that a program of slowly progressive strength training with no upper limit on the amount of weight that may be lifted would gradually increase the physiologic capacity of the arm so that common activities represent a decreasing percentage of maximal capacity. Theoretically, this increased capacity should decrease the risk that daily activities put stress on the lymphatic system of the affected side. The Physical Activity and Lymphedema (PAL) Trial is a recently completed randomized controlled exercise intervention trial that recruited 295 breast cancer survivors (141 with lymphedema at study entry, 154 at risk for lymphedema at study entry). The purpose of this report is to provide detail regarding the study design, statistical design, and protocol of the PAL trial.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Minnesota</li>
<li>Pennsylvanie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
</region>
<name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<name sortKey="Bryan, Cathy J" sort="Bryan, Cathy J" uniqKey="Bryan C" first="Cathy J." last="Bryan">Cathy J. Bryan</name>
<name sortKey="Cheville, Andrea" sort="Cheville, Andrea" uniqKey="Cheville A" first="Andrea" last="Cheville">Andrea Cheville</name>
<name sortKey="Grant, Lorita L" sort="Grant, Lorita L" uniqKey="Grant L" first="Lorita L." last="Grant">Lorita L. Grant</name>
<name sortKey="Gross, Cynthia R" sort="Gross, Cynthia R" uniqKey="Gross C" first="Cynthia R." last="Gross">Cynthia R. Gross</name>
<name sortKey="Lytle, Leslie A" sort="Lytle, Leslie A" uniqKey="Lytle L" first="Leslie A." last="Lytle">Leslie A. Lytle</name>
<name sortKey="Troxel, Andrea B" sort="Troxel, Andrea B" uniqKey="Troxel A" first="Andrea B." last="Troxel">Andrea B. Troxel</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006801 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006801 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:09-0268266 |texte= Physical activity and lymphedema (the PAL trial): Assessing the safety of progressive strength training in breast cancer survivors }}
This area was generated with Dilib version V0.6.31. |